Views & Analysis A new age: the real-world development pathway Pharma must be prepared to work collaboratively to establish the best benefit-risk profiles and outcomes.
News FDA and EMA to work more closely on paediatric drug regulati... FDA and EMA hope to streamline development of paediatric plans.
Views & Analysis Could the EMA really stay in London? After the UK voted to leave Europe, its seems obvious that the European Medicines Agency will have to leave London - but GSK’s Andrew Witty and others hope it might stay.
News Novartis' LEE011 on fast track to challenge Ibrance US regulator grants fast review for breast cancer drug.
News EU regulator begins publishing detailed study data European Medicines Agency proactively publishes clinical study reports for first time.
News Samsung Bioepis files Herceptin biosimilar in EU South Korean firm trying to copy breast cancer blockbuster.
News Immunovant's thyroid eye disease drug flunks pivotal trials Immunovant shares were sliding today after it reported that FcRn blocker batoclimab failed a pair of phase 3 trials in thyroid eye disease.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
